Tekmira stock soars after FDA relaxes precautions on experimental Ebola drug
TORONTO - Shares of Tekmira Pharmaceuticals Corp. (TSX:TKM) shot up about 47 per cent Friday following a U.S. regulatory decision that relaxes safety precautions on the Vancouver-based company's experimental drug for treating Ebola.
The rare disease has killed nearly 1,000 people in West Africa since an outbreak began in March.
Tekmira has a $140-million contract from the U.S. government to develop its drug TKM-Ebola but last month a small human trial of the experimental drug was put on hold after safety issues emerged.
The company said Thursday that the U.S. Food and Drug Administration has "verbally confirmed" that the hold has been modified so Tekmira can make the drug available, even though it has yet to be proven safe and effective.
Tekmira stock jumped $7.39 to $23 on Friday, with about 1.7 million shares traded at the Toronto Stock Exchange. The stock closed on Aug. 1 at $15.55.
Read more Business News
- Schools ready to welcome kidsCentral Okanagan - 11:55 am
- Teachers reach dealBC - 6:28 am
- 40 years without paroleVernon / N. Okanagan - 1:02 pm
- Fire crews getting upper handPenticton / S. Okanagan - 11:33 am
|QHR Technologies Inc||1.30||+0.01|
|Anavex Life Sciences||0.25||0.00|
|Copper Mountain Mining||2.69||-0.01|
|Sunrise Resources Ltd||0.02||-0.005|
|Mission Ready Services||0.30||+0.035|
Part 1 of 2 Photo: Thinkstock.com1. Move in with your parents or in-laws Explain that you're thinking strategically in moving back home. The quickest way to get into the housing market is to ma...
Article written by Linda Bustos Though I’d never recommend “lowest prices” as a unique selling proposition, I notice many retailers use a Price Match Guarantee or even a 110% Guara...
This week my wife wrote a blog for our charities website, I thought you may enjoy reading it here: I was planning to write about the incredible philanthropic Miss Angelina when, funnily enough, she ...